Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
The role of interleukin-17 in the pathogenesis of rheumatoid arthritis
Current Rheumatology Reports, 10/12/09
Gaffen SL – Interleukin (IL)–17 (also known as IL–17A), the signature cytokine of the newly described T helper 17 (Th17) cell population, has been implicated in the pathogenesis of numerous autoimmune diseases including rheumatoid arthritis. This article discusses the history of the discovery of Th17 cells, the potential mechanisms of action of IL–17 in autoimmunity, and perspectives for IL–17–targeted cytokine therapy.
Related Articles
Certolizumab Pegol: In Rheumatoid Arthritis
BioDrugs, 11/11/09
Relevance Score: 84%
Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial
Clinical Therapeutics, 10/15/09
Relevance Score: 84%
Assistive technology for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 84%
Rheumatoid Arthritis and Tuberculous Arthritis: Differentiating MRI Features
American Journal of Roentgenology, 10/26/09
Relevance Score: 83%
The association between arthritis and psychiatric disorders; results from a longitudinal population-based study
Journal of Psychosomatic Research, 10/12/09
Relevance Score: 83%
Today in Rheumatic/Autoimmune...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on the genetic risk factors for rheumatoid arthritis
Expert Review of Clinical Immunology, 12/18/09
Non-avian-derived hyaluronan for the treatment of osteoarthritis of the knee
Expert Review of Clinical Immunology, 12/18/09
Anti-TNF-[alpha] therapy with infliximab in spondyloarthritides
Expert Review of Clinical Immunology, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


